CLINICAL_TRIALS
trial_result
· 2015-12-22
Clinical Trial Update: Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II [Phase 2]
Summary
Phase 2 study evaluating argatroban for management of heparin-induced thrombocytopenia type II; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Heparin-induced Thrombocytopenia Type II | Phase 2 | Status: COMPLETED | Results posted: 2015-12-22